Efficacy and safety of exenatide in Chinese patients with type 2 diabetes inadequately controlled with metformin or metformin and a sulfonylurea

GAO Yan,NING Guang,JIA Wei-Ping

DOI: https://doi.org/10.3969/j.issn.1006-6187.2012.11.017

2012-01-01

Abstract:Objective To evaluate the efficacy of exenatide in Chinese patients with type 2 diabetes(T2DM) inadequately controlled with metformin and safety or metformin plus a sulfonylurea.Methods Patients taking metformin(MET) alone or with a sulphonylurea(SU) were randomly assigned to exenatide 5 ug then 10 ug twice-daily for 4 and 12 weeks,respectively,or placebo.The primary endpoint was baseline versus endpoint HbA1c change.Results Endpoint HbA1c reduction(mean [95% CI]) with exenatide was superior to placebo(-1.2% vs-0.3%,difference-0.8%,P<0.01).More exenatide-than placebo-treated patients achieved HbA1c ≤7%(46% vs 14% P<0.01).Exenatide reduced postprandianl glucose excursions(pre-minus postmeal levels) compared with placebo after breakfast and dinner(P<0.01).At end point,weight reduction was greater with exenatide than placebo(LS mean difference was-1.2,P<0.01).Conclusion Exenatide treatment improveds glycaemic control in Chinese patients with T2DM and hasd a similar safety profile as in non-Asian patients.